Publisher Correction: Oncolytic virus VG161 in refractory hepatocellular carcinoma

Yinan Shen^#^{1

2}, Xueli Bai^#^{1

2}, Qi Zhang^#^{1

2}, Xingmei Liang^#³, Xinyan Jin⁴, Zeda Zhao², Wei Song², Qian Tan⁵, Ronghua Zhao⁵, William Jia^{5

6

7}, Shanzhi Gu⁸, Guoming Shi⁹, Ziwei Zheng⁵, Guyue Wei⁴, Youlei Wang¹⁰, Tian Fang¹, Yuwei Li^{1

2}, Zijun Wang², Zifan Yang², Sida Guo², Danni Lin^{1

2}, Fang Wei², Lei Wang¹¹, Xiaoli Sun¹¹, Aijun Qin⁵, Longshen Xie⁷, Yeting Qiu⁵, Wenqing Bao⁵, Shah Rahimian⁶, Manu Singh⁶, Yanal Murad⁶, Jianying Shang⁵, Min Chu⁵, Maoliang Huang⁷, Jun Ding^{5

6}, Wei Chen¹, Yufu Ye¹, Yiwen Chen^{1

2}, Xiang Li^{1

2}, Tingbo Liang^{12

13}

Affiliations

¹ Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China.
³ Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
⁴ Department of Ultrasound Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
⁵ Shanghai Virogin Biotech, Shanghai, China.
⁶ Virogin Biotech Canada, Richmond, British Columbia, Canada.
⁷ CNBG-Virogin Biotech (Shanghai), Shanghai, China.
⁸ Department of Interventional Radiology, Hunan Cancer Hospital, Changsha, China.
⁹ Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
¹⁰ Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
¹¹ Department of Radiotherapy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
¹² Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. liangtingbo@zju.edu.cn.
¹³ Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China. liangtingbo@zju.edu.cn.

^# Contributed equally.

Published Erratum

Yinan Shen et al. Nature. 2025 May.

. 2025 May;641(8062):E5.

doi: 10.1038/s41586-025-09022-x.

¹ Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China.
³ Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
⁴ Department of Ultrasound Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
⁵ Shanghai Virogin Biotech, Shanghai, China.
⁶ Virogin Biotech Canada, Richmond, British Columbia, Canada.
⁷ CNBG-Virogin Biotech (Shanghai), Shanghai, China.
⁸ Department of Interventional Radiology, Hunan Cancer Hospital, Changsha, China.
⁹ Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, China.
¹⁰ Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
¹¹ Department of Radiotherapy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
¹² Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. liangtingbo@zju.edu.cn.
¹³ Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China. liangtingbo@zju.edu.cn.

^# Contributed equally.

No abstract available

Erratum for

Oncolytic virus VG161 in refractory hepatocellular carcinoma.
Shen Y, Bai X, Zhang Q, Liang X, Jin X, Zhao Z, Song W, Tan Q, Zhao R, Jia W, Gu S, Shi G, Zheng Z, Wei G, Wang Y, Fang T, Li Y, Wang Z, Yang Z, Guo S, Lin D, Wei F, Wang L, Sun X, Qin A, Xie L, Qiu Y, Bao W, Rahimian S, Singh M, Murad Y, Shang J, Chu M, Huang M, Ding J, Chen W, Ye Y, Chen Y, Li X, Liang T. Shen Y, et al. Nature. 2025 May;641(8062):503-511. doi: 10.1038/s41586-025-08717-5. Epub 2025 Mar 19. Nature. 2025. PMID: 40108464 Clinical Trial.